Intracoronary β‐irradiation enhances balloon‐injury‐induced tissue factor expression in the porcine injury model

References

• Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002; 359: 551–557.
   PubMed Web of Science ®Google Scholar
• Grise MA, Massullo V, Jani S et al. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2002; 105: 2737–40.
   PubMedGoogle Scholar
• Wiedemann JG, Marboe C, Amols H, Schwartz A, Weinberger J. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol 1994; 23: 1491–98.
   PubMedGoogle Scholar
• Venn V, Popowski Y, de Bruyne B et al. Endoluminal beta- radiation therapy for the prevention of coronary restenosis after balloon angioplasty. N Engl J Med 2001; 344: 243–49.
   PubMedGoogle Scholar
• Leon MB, Teirstein PS, Moses JW et al. Localized intra- coronary gamma-radiation therapy to inhibit the recur- rence of restenosis after stenting. N Engl J Med 2001; 344: 250–56.
   PubMed Web of Science ®Google Scholar
• Waksman R. Late thrombosis after radiation: sitting on a time bomb. Circulation 1999; 100: 780–82.
   PubMedGoogle Scholar
• Costa MA, Sabate M, Serrano P et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999; 100: 789–92.
   PubMed Web of Science ®Google Scholar
• Eldor A, Vlodavsky I, HyAm E, Atzmon R, Fuks Z. The effect of radiation on prostacyclin (PGI-2) production by cultured endothelial cells. Prostaglandins 1983; 25: 263–79.
   PubMedGoogle Scholar
• Ts'ao C, Ward W. Acute radiation effects on the content and release of plasminogen activator activity in cultured aortic endothelial cells. Radiat Res 1985; 101: 394–401.
   Google Scholar
• Zhou Q, Zhao Y, Li P, Bai X, Ruan C. Thrombomodulin as a marker of radiation induced endothelial cell injury. Radiat Res 1992; 131:285–89.
   PubMedGoogle Scholar
• Verheij M, Dewit LG, Boomgaard MN, Brinkman HJ, van Mourik JA. Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor. Radiat Res 1994; 137: 202–207.
   PubMed Web of Science ®Google Scholar
• Verheij M, Dewit L, van Mourik J. The effect of ionizing radiation on endothelial tissue factor activity and its cellular localization. Thromb Haemost 1995; 73: 894–95.
   PubMedGoogle Scholar
• Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vase Biol 2002; 22: 539–48.
   PubMed Web of Science ®Google Scholar
• Brand K, Banka CL, Mackman N, Terkeltaub RA, Fan ST, Curtiss LK. Oxidized LDL enhances lipopolysaccharide- induced tissue factor expression in human adherent monocytes. Arterioscler Thromb 1994; 14: 790–97.
   PubMedGoogle Scholar
• Drake TA, Hannani K, Fei HH, Lavi S, Berliner JA. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol 1991; 138: 601–607.
   PubMed Web of Science ®Google Scholar
• Penn MS, Patel CV, Cui MZ, DiCorleto PE, Chisolm GM. LDL increases inactive tissue factor on vascular smooth muscle cell surfaces: hydrogen peroxide activates latent cell surface tissue factor. Circulation 1999; 99: 1753–59.
   PubMed Web of Science ®Google Scholar
• Singh R, Pan S, Mueske CS et al. Role for tissue factor pathway in murine model of vascular remodeling. Circ Res 2001; 89: 71–76.
   PubMed Web of Science ®Google Scholar
• Jander S, Sitzer M, Wendt A et al. Expression of tissue factor in high-grade carotid artery stenosis: association with plaque destabilization. Stroke 2001; 32: 850–54.
   PubMed Web of Science ®Google Scholar
• Toschi V, Gallo R, Lettino M et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594–99.
   PubMed Web of Science ®Google Scholar
• Annex BH, Denning SM, Channon KM et al. Differential expression of tissue factor protein in directional ather- ectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619–22.
   PubMed Web of Science ®Google Scholar
• Saigo M, Abe S, Ogawa M et al. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction. Thromb Hae- most 2001; 86: 1197–203.
   PubMedGoogle Scholar
• Falciani M, Gori AM, Fedi S et al. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemost 1998; 79: 495–99.
   PubMed Web of Science ®Google Scholar
• Finkelstein A, Makkar R, Doherty TM et al. Increased expression of macrophage colony-stimulating factor after coronary artery balloon injury is inhibited by intracoron- ary brachytherapy. Circulation 2002; 105: 2411–15.
   PubMedGoogle Scholar
• Virmani R, Farb A, Kolodgie FD. Histopathologic altera- tions after endovascular radiation and antiproliferative stents: similarities and differences. Herz 2002; 27: 1–6.
   PubMed Web of Science ®Google Scholar
• Scheinert D, Strnad V, Muller R et al. High-dose intra- vascular beta-radiation after de novo stent implantation induces coronary artery spasm. Circulation 2002; 105: 1420–23.
   PubMedGoogle Scholar
• Hasenstab D, Lea H, Hart CE, Lok S, Clowes AW. Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis. Circulation 2000; 101: 2651–57.
   PubMedGoogle Scholar
• Teirstein PS, Kuntz RE. New frontiers in interventional cardiology: intravascular radiation to prevent restenosis. Circulation 2001; 104: 2620–26.
   PubMedGoogle Scholar
• Hamuro T, Kamikubo Y, Nakahara Y, Miyamoto S, Funatsu A. Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells. FEBS Lett 1998; 421: 197–202.
   PubMed Web of Science ®Google Scholar
• Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89: 2429–42.
   PubMed Web of Science ®Google Scholar
• Greeno EW, Bach RR, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 1996; 75: 281–89.
   PubMed Web of Science ®Google Scholar
• Cercek B, Yamashita M, Dimayuga P et al. Nuclear factor- kB activity and arterial response to balloon injury. Atherosclerosis 1997; 131: 59–66.
   PubMed Web of Science ®Google Scholar
• Hallahan D. Radiation-mediated gene expression in the pathogenesis of the clinical radiation response. Semin Radiat Oncol 1996; 6: 250–67.
   PubMedGoogle Scholar
• Mackman N. Regulation of the tissue factor gene. Thromb Haemostasis 1997; 78: 747–54.
   PubMed Web of Science ®Google Scholar
• Bavendiek U, Libby P, Kilbride M, Reynolds R, Mackman N, Schonbeck U. Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J Biol Chem. 2002; 277: 25032–39.
   PubMed Web of Science ®Google Scholar
• Shah PK. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis? Circulation 2002; 105: 270–271.
   PubMedGoogle Scholar
• Park SJ, Shim WH, Ho DS et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003; 348: 1537–45.
   PubMed Web of Science ®Google Scholar
• Sousa JE, Costa MA, Abizaid AC et al. Sustained suppres- sion of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104: 2007–11.
   PubMed Web of Science ®Google Scholar
• Kereiakes DJ. Hippocrates revisited: the evidence for drug- eluting stents. Circulation 2003; 107: 3012–14.
   PubMedGoogle Scholar
• O'Neill WW, Leon MB. Drug-eluting stents: costs versus clinical benefit. Circulation 2003; 107: 3008–11.
   PubMed Web of Science ®Google Scholar
• Lemos PA, Serruys PW, Sousa JE. Drug-eluting stents: cost versus clinical benefit. Circulation 2003; 107: 3003–3007.
   PubMed Web of Science ®Google Scholar
• Lemos PA, Saia F, Ligthart JM et al. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003; 108: 257–60.
   PubMed Web of Science ®Google Scholar
• Saia F, Lemos PA, Sianos G et al. Effectiveness of sirolimus- eluting stent implantation for recurrent in-stent restenosis after brachytherapy. Am J Cardiol 2003; 92: 200–203.
   PubMed Web of Science ®Google Scholar
• Kereiakes DJ. Hippocrates revisited: the evidence for drug- eluting stents. Circulation 2003; 107: 3012–14.
   PubMedGoogle Scholar
• O'Neill WW, Leon MB. Drug-eluting stents: costs versus clinical benefit. Circulation 2003; 107: 3008–3011.
   PubMed Web of Science ®Google Scholar
• Lemos PA, Serruys PW, Sousa JE. Drug-eluting stents: cost versus clinical benefit. Circulation 2003; 107: 3003–3007.
   PubMed Web of Science ®Google Scholar
• Waksman R, Weinberger J. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive. Circulation 2003; 108: 386–88.
   PubMedGoogle Scholar
• Teirstein PS, King S. Vascular radiation in a drug-eluting stent world: it's not over till it's over. Circulation 108: 384–85.
   PubMedGoogle Scholar
• SoRelle R. Repeating intracoronary radiation an option for in-stent restenosis, even after initial failure. Circulation 2003; 108: e9010-ll.
   Google Scholar
• Waksman R, Lew R, Ajani AE et al. Repeat intracoronary radiation for recurrent in-stent restenosis in patients who failed intracoronary radiation. Circulation 2003; 108: 654–56.
   PubMedGoogle Scholar
• Abendschein DR, MengYY, Torr-Brown S, Sobel BE. Main- tenance of coronary patency after fibrinolysis with tissue factor pathway inhibitor. Circulation 1995; 92: 944–49.
   PubMed Web of Science ®Google Scholar
• Golino P, Cirillo P, Calabro' P et al. Expression of exo- genous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries. J Am Coll Cardiol 2001; 38: 569–76.
   PubMed Web of Science ®Google Scholar
• Kaiser B, Hoppensteadt DA, Fareed J. Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders. Expert Opin Investig Drugs 2001; 10: 1925–35.
   PubMed Web of Science ®Google Scholar